Example of Drug, Healthcare and Patient Safety format
Recent searches

Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format Example of Drug, Healthcare and Patient Safety format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Drug, Healthcare and Patient Safety — Template for authors

Publisher: Dove Medical Press
Categories Rank Trend in last 3 yrs
Health Policy #138 of 242 down down by 96 ranks
Pharmacology #207 of 297 down down by 61 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 69 Published Papers | 134 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 10/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Taylor and Francis

Quality:  
High
CiteRatio: 3.2
SJR: 1.216
SNIP: 3.119
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.2
SJR: 1.864
SNIP: 1.641
open access Open Access

Springer

Quality:  
High
CiteRatio: 4.8
SJR: 0.972
SNIP: 1.782
open access Open Access

Springer

Quality:  
High
CiteRatio: 4.3
SJR: 0.633
SNIP: 1.433

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.9

24% from 2019

CiteRatio for Drug, Healthcare and Patient Safety from 2016 - 2020
Year Value
2020 1.9
2019 2.5
2018 2.5
2017 3.6
2016 3.3
graph view Graph view
table view Table view

0.53

12% from 2019

SJR for Drug, Healthcare and Patient Safety from 2016 - 2020
Year Value
2020 0.53
2019 0.473
2018 0.343
2017 0.481
2016 0.531
graph view Graph view
table view Table view

1.123

23% from 2019

SNIP for Drug, Healthcare and Patient Safety from 2016 - 2020
Year Value
2020 1.123
2019 1.465
2018 0.866
2017 0.822
2016 0.747
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 24% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 12% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 23% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Drug, Healthcare and Patient Safety

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Dove Medical Press

Drug, Healthcare and Patient Safety

Drug, Healthcare and Patient Safety is an international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery. The journal is characterized by t...... Read More

Health Policy

Pharmacology

Medicine

i
Last updated on
09 Jul 2020
i
ISSN
1179-1365
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Blue faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. Specular andreev reflection in graphene. Phys. Rev. Lett., 97(6):067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.2147/DHPS.S28801
Clinical use of anti-TNF therapy and increased risk of infections
Tauseef Ali1, Sindhu Kaitha1, Sultan Mahmood, Abdul Ftesi, Jordan Stone, Michael S. Bronze

Abstract:

Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important agents in the treatment of many chronic inflammatory diseases, especially in cases refractory to conventional treatment modalities. However, opportunistic infections have become a major safety concern in patients on anti-TNF therapy, and ph... Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important agents in the treatment of many chronic inflammatory diseases, especially in cases refractory to conventional treatment modalities. However, opportunistic infections have become a major safety concern in patients on anti-TNF therapy, and physicians who utilize these agents must understand the increased risks of infection. A literature review of the published data on the risk of bacterial, viral, fungal, and parasitic infections associated with anti-TNF therapy was performed and the clinical presentation, diagnostic tests, management, and prevention of opportunistic infections in patients receiving anti-TNF therapy were reviewed. Awareness of the therapeutic potential and associated adverse events is necessary for maximizing therapeutic benefits while minimizing adverse effects from anti-TNF treatments. Patients should be adequately vaccinated when possible and closely monitored for early signs of infection. When serious infections occur, withdrawal of anti-TNF therapy may be necessary until the infection has been identified and properly treated. read more read less

Topics:

Adverse effect (53%)53% related to the paper
View PDF
203 Citations
open accessOpen access Journal Article DOI: 10.2147/DHPS.S71976
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies
Jay L. Goldstein1, Byron L Cryer2

Abstract:

Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic agents and are among the most commonly used classes of medications worldwide. However, their use has been associated with potentially serious dose-dependent gastrointestinal (GI) complications such as upper GI bleeding. GI complication... Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic agents and are among the most commonly used classes of medications worldwide. However, their use has been associated with potentially serious dose-dependent gastrointestinal (GI) complications such as upper GI bleeding. GI complications resulting from NSAID use are among the most common drug side effects in the United States, due to the widespread use of NSAIDs. The risk of upper GI complications can occur even with short-term NSAID use, and the rate of events is linear over time with continued use. Although gastroprotective therapies are available, they are underused, and patient and physician awareness and recognition of some of the factors influencing the development of NSAID-related upper GI complications are limited. Herein, we present a case report of a patient experiencing a gastric ulcer following NSAID use and examine some of the risk factors and potential strategies for prevention of upper GI mucosal injuries and associated bleeding following NSAID use. These risk factors include advanced age, previous history of GI injury, and concurrent use of medications such as anticoagulants, aspirin, corticosteroids, and selective serotonin reuptake inhibitors. Strategies for prevention of GI injuries include anti-secretory agents, gastroprotective agents, alternative NSAID formulations, and nonpharmacologic therapies. Greater awareness of the risk factors and potential therapies for GI complications resulting from NSAID use could help improve outcomes for patients requiring NSAID treatment. read more read less
View PDF
134 Citations
open accessOpen access Journal Article DOI: 10.2147/DHPS.S7634
Antidepressant-associated sexual dysfunction: impact, effects, and treatment.
Agnes Higgins1, Michael Nash, Aileen M Lynch

Abstract:

Sexual dysfunction is a common side effect of antidepressants and can have significant impact on the person's quality of life, relationships, mental health, and recovery. The reported incidence of sexual dysfunction associated with antidepressant medication varies considerably between studies, making it difficult to estimate ... Sexual dysfunction is a common side effect of antidepressants and can have significant impact on the person's quality of life, relationships, mental health, and recovery. The reported incidence of sexual dysfunction associated with antidepressant medication varies considerably between studies, making it difficult to estimate the exact incidence or prevalence. The sexual problems reported range from decreased sexual desire, decreased sexual excitement, diminished or delayed orgasm, to erection or delayed ejaculation problems. There are a number of case reports of sexual side effects, such as priapism, painful ejaculation, penile anesthesia, loss of sensation in the vagina and nipples, persistent genital arousal and nonpuerperal lactation in women. The focus of this article is to explore the incidence, pathophysiology, and treatment of antidepressant iatrogenic sexual dysfunction. read more read less

Topics:

Sexual dysfunction (75%)75% related to the paper, Delayed ejaculation (70%)70% related to the paper, Vagina (53%)53% related to the paper, Sex organ (52%)52% related to the paper
View PDF
132 Citations
open accessOpen access Journal Article DOI: 10.2147/DHPS.S68786
Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam
Appolinary Kamuhabwa1, Emmanuel Charles1

Abstract:

Tanzania has recently experienced a significant rise in the burden of diabetes, and it is estimated that more than 400,000 people are living with diabetes. A major concern in the management of diabetes is the occurrence of diabetic complications that occur as a result of poor glycemic control. Identification of the factors as... Tanzania has recently experienced a significant rise in the burden of diabetes, and it is estimated that more than 400,000 people are living with diabetes. A major concern in the management of diabetes is the occurrence of diabetic complications that occur as a result of poor glycemic control. Identification of the factors associated with poor glycemic control is important in order to institute appropriate interventions for the purpose of improving glycemic control and prevention of chronic complications. The aim of this study was to determine the level of glycemic control and explore the factors associated with poor glycemic control among patients with type 2 diabetes mellitus (T2DM). A cross-sectional study was carried out at the diabetic clinics for T2DM patients at the national and municipal hospitals in Dar es Salaam. A total of 469 patients were enrolled over a period of 8 weeks from March 2013 to May 2013. Patients' information such as sociodemographic characteristics, self-care management behaviors, and medication adherence were obtained through interviews. Blood pressure, weight, and height were measured during the day of the interview. All available last readings for fasting blood glucose (FBG) measurements, lipid profile, and other clinical characteristics were obtained from patients' records. The mean age of patients was 54.93 years. The majority (63.5%) of patients were females and only eight patients had records of lipid profile measurements. Out of 469 patients, 69.7% had FBG of ≥7.2 mmol/L, indicating poor glycemic control. Females aged between 40 years and 59 years had significantly higher poor glycemic control (76.1%) as compared with their male counterparts. Thirty-eight percent of patients had poor medication adherence, which was associated with poor glycemic control. The proportion of poor glycemic control increased with age. A significantly high proportion of poor glycemic control was observed in patients who had had the disease for more than 20 years since diagnosis. Factors associated with poor glycemic control included lack of health insurance, using more than one oral hypoglycemic agent, normal body mass index, obesity, and nonadherence to diabetic medications. Patients in this study had generally poor glycemic control. From these findings it is recommended that diabetic patients should be routinely screened for lipid profile to determine levels of cholesterol, triglycerides, and low-density lipoproteins, which are risk factors for cardiovascular events. An education program should be developed to educate patients on the importance of medication adherence and weight management for better glycemic control. read more read less

Topics:

Glycemic (74%)74% related to the paper, Type 2 diabetes (53%)53% related to the paper, Diabetes mellitus (51%)51% related to the paper
View PDF
90 Citations
open accessOpen access Journal Article DOI: 10.2147/DHPS.S107344
Point prevalence of hospital-acquired infections in two teaching hospitals of Amhara region in Ethiopia.
Walelegn Worku Yallew1, Abera Kumie2, Feleke Moges Yehuala1

Abstract:

Purpose Hospital-acquired infection (HAI) is a major safety issue affecting the quality of care of hundreds of millions of patients every year, in both developed and developing countries, including Ethiopia. In Ethiopia, there is no comprehensive research that presents the whole picture of HAIs in hospitals. The objective of ... Purpose Hospital-acquired infection (HAI) is a major safety issue affecting the quality of care of hundreds of millions of patients every year, in both developed and developing countries, including Ethiopia. In Ethiopia, there is no comprehensive research that presents the whole picture of HAIs in hospitals. The objective of this study was to examine the nature and extent of HAIs in Ethiopia. Methods A repeated cross-sectional study was conducted in two teaching hospitals. All eligible inpatients admitted for at least 48 hours on the day of the survey were included. The survey was conducted in dry and wet seasons of Ethiopia, that is, in March to April and July 2015. Physicians and nurses collected the data according to the Centers for Disease Control and Prevention definition of HAIs. Coded and cleaned data were transferred to SPSS 21 and STATA 13 for analysis. Univariate and multivariable logistic regression analyses were used to examine the prevalence of HAIs and relationship between explanatory and outcome variables. Results A total of 908 patients were included in this survey, the median age of the patients was 27 years (interquartile range: 16-40 years). A total of 650 (71.6%) patients received antimicrobials during the survey. There were 135 patients with HAI, with a mean prevalence of 14.9% (95% confidence interval 12.7-17.1). Culture results showed that Klebsiella spp. (22.44%) and Staphylococcus aureus (20.4%) were the most commonly isolated HAI-causing pathogens in these hospitals. The association of patient age and hospital type with the occurrence of HAI was statistically significant. Conclusion It was observed that the prevalence of HAI was high in the teaching hospitals. Surgical site infections and pneumonia were the most common types of HAIs. Hospital management should give more attention to promoting infection prevention practice for better control of HAIs in teaching hospitals. read more read less

Topics:

Hospital-acquired infection (50%)50% related to the paper
View PDF
77 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Drug, Healthcare and Patient Safety.

It automatically formats your research paper to Dove Medical Press formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Drug, Healthcare and Patient Safety format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Drug, Healthcare and Patient Safety in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Drug, Healthcare and Patient Safety guidelines and auto format it.

2. Do you follow the Drug, Healthcare and Patient Safety guidelines?

Yes, the template is compliant with the Drug, Healthcare and Patient Safety guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Drug, Healthcare and Patient Safety?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Drug, Healthcare and Patient Safety citation style.

4. Can I use the Drug, Healthcare and Patient Safety templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Drug, Healthcare and Patient Safety.

5. Can I use a manuscript in Drug, Healthcare and Patient Safety that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Drug, Healthcare and Patient Safety that you can download at the end.

6. How long does it usually take you to format my papers in Drug, Healthcare and Patient Safety?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Drug, Healthcare and Patient Safety.

7. Where can I find the template for the Drug, Healthcare and Patient Safety?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Drug, Healthcare and Patient Safety's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Drug, Healthcare and Patient Safety's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Drug, Healthcare and Patient Safety an online tool or is there a desktop version?

SciSpace's Drug, Healthcare and Patient Safety is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Drug, Healthcare and Patient Safety?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Drug, Healthcare and Patient Safety?”

11. What is the output that I would get after using Drug, Healthcare and Patient Safety?

After writing your paper autoformatting in Drug, Healthcare and Patient Safety, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Drug, Healthcare and Patient Safety's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Drug, Healthcare and Patient Safety?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Drug, Healthcare and Patient Safety. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Drug, Healthcare and Patient Safety?

The 5 most common citation types in order of usage for Drug, Healthcare and Patient Safety are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Drug, Healthcare and Patient Safety?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Drug, Healthcare and Patient Safety's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Drug, Healthcare and Patient Safety in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Drug, Healthcare and Patient Safety Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Drug, Healthcare and Patient Safety formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template